JAMES A BANKSON to In Situ Nick-End Labeling
This is a "connection" page, showing publications JAMES A BANKSON has written about In Situ Nick-End Labeling.
Connection Strength
0.043
-
Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
Score: 0.022
-
TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Clin Cancer Res. 2010 May 01; 16(9):2591-604.
Score: 0.021